Expert Financial Analysis and Reporting

Recent Reports

• Northwest Biotherapeutics: Why I Believe there is a High Probability for Approval of DCVax-L (NWBO, Buy, $0.21) (0)

Recent Blogs

• Northwest Biotherapeutics: A More Thorough Discussion of the Potential Survival Tail of DCVax-L in Newly Diagnosed GBM than Originally Presented in My September 17, 2019 Report (NWBO, Buy, $0.25) (0)
• Cryoport: Pre-Announcement of 4Q Sales Negatively Impacted Stock; I Remain Bullish on the Stock (CYRX, Buy, $18.07) (0)
• Antares: Update on Sales Projections for Xyosted (ATRS, $3.30, Buy) (0)
• Portola: My Investment Thinking After the Sharp Price Drop (PTLA, Buy, $14.85) (0)
• Cryoport; Sales of CAR-T Products Yescarta and Kymriah are In-line with My Projections (CYRX, Buy, $20.67) (0)
• Novocure: First Report on this Dynamic Growth Stock with Important Similarities to Northwest Biotherapeutics (NVCR, $78.77) (0)
• Part 10 of Illegal Naked Shorting Series:  Legal Shorting of Stocks is a Loser’s Game but Illegal Naked Shorting Transforms It into a Winner’s Game (0)
• Cryoport: Exciting Clinical Data on CAR-T Drugs Points to Dramatic Growth (CYRX, Buy, $14.59) (0)
• Part 9 of Illegal Naked Shorting Series:  The Risk/ Reward of Shorting Versus Buying Stocks is Extremely Unfavorable (0)
• Antares: Detailed Sales and Earnings Projections for 2020, 2021 and 2022 (ATRS, Buy, $4.86) (0)
• Part 8: Illegal Naked Shorting Series: Who or What is Cede and What Role Does Cede Play in the Trading of Stocks? (0)

Social Feeds

• • $ CYRX Cryoport: The Bristol-Myers Acquisition of Celgene is a Validation of my Investment Thesis for Cryoport… https://t.co/TQ4KFbritg, Jan 09
  • $PTLA Portola: Tidbits from Presentation at JP Morgan Healthcare Conference (PTLA, Buy, $21.96) https://t.co/76AuWyEbFH, Jan 09
  • $BMY Negative Market Reaction to Celgene Acquisition is a Buying Opportunity https://t.co/0aybnueJbx, Jan 04
  • $nwbo $46 million non-dilutive financing provides major boost to investment outlook. See my report. https://t.co/pidvWRoYUR, Dec 17
  • $cyrx Cryoport raises a $25 million warchest for acquisiitons https://t.co/OyAt5ZlY87, Dec 17